Rhode Island Postpartum Hypertension Remote Surveillance

This study is looking at ways to help new mothers manage high blood pressure (hypertension) after pregnancy. It compares two approaches: RI-SPHERES and a standard self-measured blood pressure program. RI-SPHERES involves a care manager who helps you communicate through an app for your medical needs. The standard program uses a self-measured blood pressure program where you record your blood pressure readings in an online portal. The goal is to see if RI-SPHERES is just as good as the standard program in preventing long-lasting high blood pressure at six weeks postpartum and ensuring you receive preventive care within a year of delivery. The study is for women aged 18 to 60 who have experienced high blood pressure during or after pregnancy and live in Rhode Island. You also need to speak English, Spanish, Portuguese, or Haitian-Creole and own a smartphone. The study is currently recruiting about 1536 participants, but its overall status is unclear.

Study design
This is a hybrid type 1 non-inferiority implementation effectiveness trial with a planned enrollment of 1536 participants. It compares two behavioral interventions.
What's involved
Participants will be introduced to a care manager either virtually or in-person, who will demonstrate how to use an app or an online portal to record blood pressure measurements and communicate.
Compensation
Not stated in the trial record.
Follow-up
The study measures persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06842875

Rhode Island - Statewide Postpartum Hypertension Remote Surveillance

Recruiting
NAAges 18–60InterventionalHealth services
Women and Infants Hospital of Rhode Island
~1,536 participants
Updated 2025-06-17 on ClinicalTrials.gov
What's tested:RI-SPHERESStandard self-measured blood pressure program

At a glance

Recruiting sites
3 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Persistent hypertension
Measured over Six weeks postpartum
Hypertension in Pregnancy
Postpartum Preeclampsia
Postpartum Complication
5 sites across 1 states
Rhode Island5
Stephanie Nunez, Research Coordinator
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Postpartum patient aged 18 years or more at any birthing hospital in Rhode Island
Diagnosed during pregnancy or after delivery with hypertensive disorder of pregnant
English-, Spanish-, Portuguese-, or Haitian-Creole-speaking
Smartphone ownership

Exclusion

Prior enrollment in this trial
Prisoners or incarcerated people
Inability or unwillingness to provide informed consent
Inability to communicate with study team, despite an interpreter
  • Persistent hypertensionSix weeks postpartum

    Persistent stage II hypertension will be defined as systolic blood pressure of 140 mmHg or higher and/or diastolic blood pressure of 90 mmHg or higher